These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
581 related articles for article (PubMed ID: 18520310)
1. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population. Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310 [TBL] [Abstract][Full Text] [Related]
2. Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population. Hartung DM; Touchette DR; Ketchum KL; Haxby DG; Goldberg BW Clin Ther; 2004 Sep; 26(9):1518-32. PubMed ID: 15531015 [TBL] [Abstract][Full Text] [Related]
3. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly. Liu SZ; Romeis JC Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666 [TBL] [Abstract][Full Text] [Related]
4. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis. Khanna R; Smith MJ Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087 [TBL] [Abstract][Full Text] [Related]
5. Differences in the cost of antidepressants across state Medicaid programs. Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875 [TBL] [Abstract][Full Text] [Related]
6. Changes in drug utilization following the outpatient prescription drug cost-sharing program--evidence from Taiwan's elderly. Liu SZ; Romeis JC Health Policy; 2004 Jun; 68(3):277-87. PubMed ID: 15113639 [TBL] [Abstract][Full Text] [Related]
8. Variation in outpatient mental health service utilization under capitation. Chou AF; Wallace N; Bloom JR; Hu TW J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481 [TBL] [Abstract][Full Text] [Related]
9. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma. Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179 [TBL] [Abstract][Full Text] [Related]
10. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy. Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768 [TBL] [Abstract][Full Text] [Related]
11. Effect of a medication copayment increase in veterans with schizophrenia. Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234 [TBL] [Abstract][Full Text] [Related]
12. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure. Bagchi AD; Esposito D; Kim M; Verdier J; Bencio D Clin Ther; 2007 Aug; 29(8):1771-83. PubMed ID: 17919558 [TBL] [Abstract][Full Text] [Related]
13. The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities. Li X; Guh D; Lacaille D; Esdaile J; Anis AH Health Policy; 2007 Aug; 82(3):340-7. PubMed ID: 17134787 [TBL] [Abstract][Full Text] [Related]
14. Impact of disease management on health care utilization: evidence from the "Florida: A Healthy State (FAHS)" Medicaid Program. Afifi AA; Morisky DE; Kominski GF; Kotlerman JB Prev Med; 2007 Jun; 44(6):547-53. PubMed ID: 17350086 [TBL] [Abstract][Full Text] [Related]
15. Impact of policy changes on emergency department use by Medicaid enrollees in Oregon. Lowe RA; Fu R; Gallia CA Med Care; 2010 Jul; 48(7):619-27. PubMed ID: 20548256 [TBL] [Abstract][Full Text] [Related]
16. Impact of a criteria-based reimbursement policy on the use of respiratory drugs delivered by nebulizer and health care services utilization in Nova Scotia, Canada. Kephart G; Sketris IS; Bowles SK; Richard ME; Cooke CA Pharmacotherapy; 2005 Sep; 25(9):1248-57. PubMed ID: 16164398 [TBL] [Abstract][Full Text] [Related]
17. Prescription drug access: not just a Medicare problem. Cunningham PJ Issue Brief Cent Stud Health Syst Change; 2002 Apr; (51):1-4. PubMed ID: 11977267 [TBL] [Abstract][Full Text] [Related]
18. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population. Balkrishnan R; Byerly WG; Camacho FT; Shrestha A; Anderson RT Am J Manag Care; 2001 Nov; 7(11):1093-100. PubMed ID: 11725812 [TBL] [Abstract][Full Text] [Related]
19. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation. Motheral BR; Henderson R Am J Manag Care; 1999 Nov; 5(11):1383-94. PubMed ID: 10662412 [TBL] [Abstract][Full Text] [Related]
20. Trends in prescription drug expenditures by Medicaid enrollees. Banthin JS; Miller GE Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]